MedTrace Logo

Evaluation of Nephure™, and the Reduction of Dietary Oxalate, in Healthy Volunteers

NCT03661216 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2018-09-19

No results posted yet for this study

Summary

The purpose of this double-blind study is to determine the effect of reducing oxalates in the diet of healthy volunteers by using Nephure, an oxalate-reducing enzyme, as compared to placebo.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Nephure Oxalate-reducing Enzyme

3g of Nephure is mixed with 8oz of water and ingested with breakfast, lunch and dinner.

OTHER

Placebo

3g of non-GMO maltodextrin is mixed with 8oz of water and ingested with breakfast, lunch and dinner.

Sponsors & Collaborators

  • Captozyme, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-11
Primary Completion
2018-08-05
Completion
2018-08-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03661216 on ClinicalTrials.gov